Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Alignment Healthcare, Inc. (ALHC)
since 2021 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Alignment Healthcare, Inc..
(See page 1 of this report.) Table 2 shows the detailed insider transactions.
This company's CIK number is 1832466.
Total stock buying since 2021: $1,158,369.
Total stock sales since 2021: $1,572,621,672.
Total stock option exercises since 2021: $0.
Table 3. Detailed insider trading at Alignment Healthcare, Inc. (ALHC) , Part 2
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2023-09-13 | Joyce Christopher J (Chief Legal and Admin. Officer) | Sale | 15,474 | 5.20 | 80,464 |
| 2023-03-31 | Freeman Robert Thomas (Chief Financial Officer) | Sale | 3,290 | 6.26 | 20,608 |
| 2023-03-29 | Cross Richard A. (SVP, General Counsel) | Sale | 1,710 | 6.11 | 10,453 |
| 2023-03-29 | Kumar Dinesh M. (Chief Med & Operating Officer) | Sale | 3,286 | 6.11 | 20,087 |
| 2023-03-29 | Freeman Robert Thomas (Chief Financial Officer) | Sale | 5,312 | 6.11 | 32,472 |
| 2023-03-29 | Maroney Dawn Christine (President, Markets) | Sale | 7,178 | 6.11 | 43,879 |
| 2023-03-29 | Kao John E (Chief Executive Officer) | Sale | 34,506 | 6.11 | 210,935 |
| 2023-03-14 | Cross Richard A. (SVP, General Counsel) | Sale | 5,516 | 6.33 | 34,899 |
| 2023-03-14 | Kumar Dinesh M. (Chief Med & Operating Officer) | Sale | 14,164 | 6.33 | 89,615 |
| 2023-03-14 | Freeman Robert Thomas (Chief Financial Officer) | Sale | 13,470 | 6.33 | 85,224 |
| 2023-03-14 | Maroney Dawn Christine (President, Markets) | Sale | 20,006 | 6.33 | 126,577 |
| 2023-03-14 | Kao John E (Chief Executive Officer) | Sale | 39,101 | 6.33 | 247,392 |
| 2023-03-09 | Konowiecki Joseph S (Chairman of the Board) | Buy | 100,000 | 6.62 | 661,600 |
| 2023-02-01 | Kumar Dinesh M. (Chief Med & Operating Officer) | Sale | 10,000 | 12.19 | 121,920 |
| 2023-01-18 | Kumar Dinesh M. (Chief Med & Operating Officer) | Sale | 1,125 | 13.01 | 14,632 |
| 2023-01-18 | Freeman Robert Thomas (Chief Financial Officer) | Sale | 1,100 | 13.01 | 14,307 |
| 2023-01-18 | Kao John E (Chief Executive Officer) | Sale | 1,100 | 13.01 | 14,309 |
| 2023-01-17 | Maroney Dawn Christine (President, Markets) | Sale | 5,000 | 12.54 | 62,720 |
| 2023-01-13 | Kumar Dinesh M. (Chief Med & Operating Officer) | Sale | 9,000 | 12.09 | 108,819 |
| 2022-12-15 | Maroney Dawn Christine (President, Markets) | Sale | 726 | 12.02 | 8,727 |
| 2022-12-01 | Kumar Dinesh M. (Chief Med & Operating Officer) | Sale | 40,000 | 13.08 | 523,160 |
| 2022-12-01 | Freeman Robert Thomas (Chief Financial Officer) | Sale | 48,000 | 13.10 | 628,896 |
| 2022-12-01 | Kao John E (Chief Executive Officer) | Sale | 50,000 | 13.11 | 655,550 |
| 2022-11-01 | Kumar Dinesh M. (Chief Med & Operating Officer) | Sale | 30,000 | 13.39 | 401,790 |
| 2022-11-01 | Freeman Robert Thomas (Chief Financial Officer) | Sale | 24,000 | 13.23 | 317,616 |
| 2022-11-01 | Kao John E (Chief Executive Officer) | Sale | 25,000 | 13.23 | 330,825 |
| 2022-10-26 | Kumar Dinesh M. (Chief Med & Operating Officer) | Sale | 10,000 | 13.02 | 130,160 |
| 2022-10-26 | Freeman Robert Thomas (Chief Financial Officer) | Sale | 24,000 | 13.08 | 313,824 |
| 2022-10-26 | Kao John E (Chief Executive Officer) | Sale | 25,000 | 13.07 | 326,850 |
| 2022-10-03 | Kumar Dinesh M. (Chief Med & Operating Officer) | Sale | 20,000 | 12.03 | 240,500 |
| 2022-09-20 | Warburg Pincus Partners Ii Holdings, L.p. | Sale | 2,044,006 | 14.61 | 29,862,927 |
| 2022-09-20 | General Atlantic (aln Hlth), L.p. | Sale | 6,955,994 | 14.61 | 101,627,072 |
| 2022-09-20 | General Atlantic (spv) Gp, Llc | Sale | 6,955,994 | 14.61 | 101,627,072 |
| 2022-09-20 | Warburg Pincus Partners Ii, L.p. | Sale | 2,044,006 | 14.61 | 29,862,927 |
| 2022-09-09 | Maroney Dawn Christine (President, Markets) | Sale | 10,250 | 16.60 | 170,191 |
| 2022-09-08 | Kumar Dinesh M. (Chief Med & Operating Officer) | Sale | 50,000 | 16.05 | 802,650 |
| 2022-09-01 | Freeman Robert Thomas (Chief Financial Officer) | Sale | 24,000 | 14.56 | 349,368 |
| 2022-09-01 | Kao John E (Chief Executive Officer) | Sale | 50,000 | 14.56 | 727,950 |
| 2022-08-23 | Warburg Pincus Partners Ii Holdings, L.p. | Sale | 682,000 | 15.50 | 10,571,000 |
| 2022-08-23 | Kumar Dinesh M. (Chief Med & Operating Officer) | Sale | 50,000 | 16.00 | 800,050 |
| 2022-08-23 | Maroney Dawn Christine (President, Markets) | Sale | 13,713 | 15.93 | 218,502 |
| 2022-08-23 | Warburg Pincus Partners Ii, L.p. | Sale | 682,000 | 15.50 | 10,571,000 |
| 2022-08-22 | Maroney Dawn Christine (President, Markets) | Sale | 16,287 | 15.90 | 259,012 |
| 2022-08-15 | Maroney Dawn Christine (President, Markets) | Sale | 1,790 | 16.60 | 29,714 |
| 2022-08-11 | Kao John E (Chief Executive Officer) | Sale | 500,000 | 15.95 | 7,976,500 |
| 2022-08-09 | Warburg Pincus Partners Ii Holdings, L.p. | Sale | 2,120,000 | 16.16 | 34,259,200 |
| 2022-08-09 | Warburg Pincus Partners Ii, L.p. | Sale | 2,120,000 | 16.16 | 34,259,200 |
| 2022-08-02 | Kao John E (Chief Executive Officer) | Sale | 848 | 14.74 | 12,499 |
| 2022-08-01 | Kumar Dinesh M. (Chief Med & Operating Officer) | Sale | 30,000 | 14.49 | 434,640 |
| 2022-08-01 | Freeman Robert Thomas (Chief Financial Officer) | Sale | 24,000 | 14.50 | 348,024 |
| 2022-08-01 | Maroney Dawn Christine (President, Markets) | Sale | 20,000 | 14.47 | 289,440 |
| 2022-08-01 | Kao John E (Chief Executive Officer) | Sale | 49,152 | 14.60 | 717,619 |
| 2022-07-11 | Kao John E (Chief Executive Officer) | Sale | 4,107 | 14.08 | 57,810 |
| 2022-07-08 | Maroney Dawn Christine (President, Markets) | Sale | 14,775 | 14.30 | 211,238 |
| 2022-07-08 | Kao John E (Chief Executive Officer) | Sale | 20,699 | 14.33 | 296,554 |
| 2022-07-07 | Maroney Dawn Christine (President, Markets) | Sale | 25,225 | 14.12 | 356,277 |
| 2022-07-07 | Kao John E (Chief Executive Officer) | Sale | 49,442 | 14.09 | 696,440 |
| 2022-07-06 | Kumar Dinesh M. (Chief Med & Operating Officer) | Sale | 20,000 | 13.04 | 260,780 |
| 2022-07-06 | Kao John E (Chief Executive Officer) | Sale | 25,752 | 13.04 | 335,934 |
| 2022-07-05 | Kumar Dinesh M. (Chief Med & Operating Officer) | Sale | 16,317 | 12.41 | 202,510 |
| 2022-07-05 | Freeman Robert Thomas (Chief Financial Officer) | Sale | 20,383 | 12.48 | 254,400 |
| 2022-07-01 | Kumar Dinesh M. (Chief Med & Operating Officer) | Sale | 10,000 | 11.40 | 113,980 |
| 2022-07-01 | Freeman Robert Thomas (Chief Financial Officer) | Sale | 12,000 | 11.40 | 136,836 |
| 2022-06-22 | Kumar Dinesh M. (Chief Med & Operating Officer) | Sale | 100 | 12.00 | 1,200 |
| 2022-06-22 | Freeman Robert Thomas (Chief Financial Officer) | Sale | 100 | 12.00 | 1,200 |
| 2022-06-21 | Kumar Dinesh M. (Chief Med & Operating Officer) | Sale | 3,583 | 12.01 | 43,035 |
| 2022-06-21 | Freeman Robert Thomas (Chief Financial Officer) | Sale | 3,517 | 12.01 | 42,249 |
| 2022-06-17 | Freeman Robert Thomas (Chief Financial Officer) | Sale | 12,000 | 11.18 | 134,112 |
| 2022-06-16 | Kumar Dinesh M. (Chief Med & Operating Officer) | Sale | 10,000 | 11.04 | 110,390 |
| 2022-06-16 | Maroney Dawn Christine (President, Markets) | Sale | 2,150 | 10.96 | 23,564 |
| 2022-06-02 | Maroney Dawn Christine (President, Markets) | Sale | 13,782 | 11.10 | 153,021 |
| 2022-04-01 | Freeman Robert Thomas (Chief Financial Officer) | Sale | 3,292 | 11.42 | 37,581 |
| 2022-03-31 | Cross Richard A. (SVP, General Counsel) | Sale | 1,592 | 11.18 | 17,792 |
| 2022-03-31 | Shrestha Rajesh (Pres., New Markets & CBO) | Sale | 14,224 | 11.18 | 158,967 |
| 2022-03-31 | Kumar Dinesh M. (Chief Medical Officer) | Sale | 3,058 | 11.18 | 34,176 |
| 2022-03-31 | Furman Donald Steven (Chief Clinical Officer) | Sale | 3,006 | 11.18 | 33,595 |
| 2022-03-31 | Freeman Robert Thomas (Chief Financial Officer) | Sale | 4,944 | 11.18 | 55,254 |
| 2022-03-31 | Maroney Dawn Christine (President, Markets) | Sale | 6,681 | 11.18 | 74,666 |
| 2022-03-31 | Kao John E (Chief Executive Officer) | Sale | 26,366 | 11.18 | 294,666 |
| 2021-11-23 | Warburg Pincus Partners Ii Holdings, L.p. | Sale | 2,033,936 | 20.11 | 40,898,385 |
| 2021-11-23 | General Atlantic (aln Hlth), L.p. | Sale | 6,259,298 | 20.11 | 125,861,964 |
| 2021-11-23 | Kumar Dinesh M. (Chief Medical Officer) | Sale | 83,367 | 20.11 | 1,676,343 |
| 2021-11-23 | Furman Donald Steven (Chief Clinical Officer) | Sale | 100,000 | 20.11 | 2,010,800 |
| 2021-11-23 | Freeman Robert Thomas (Chief Financial Officer) | Sale | 85,279 | 20.11 | 1,714,790 |
| 2021-11-23 | Maroney Dawn Christine (President, Markets) | Sale | 127,843 | 20.11 | 2,570,667 |
| 2021-11-23 | General Atlantic (spv) Gp, Llc | Sale | 6,259,298 | 20.11 | 125,861,964 |
| 2021-11-23 | Warburg Pincus Partners Ii, L.p. | Sale | 2,033,936 | 20.11 | 40,898,385 |
| 2021-11-23 | Mcclellan Mark B. | Sale | 7,500 | 20.11 | 150,810 |
| 2021-11-23 | Kao John E (Chief Executive Officer) | Sale | 419,646 | 20.11 | 8,438,241 |
| 2021-11-02 | Kao John E (Chief Executive Officer) | Sale | 29,302 | 19.93 | 583,930 |
| 2021-11-01 | Kumar Dinesh M. (Chief Medical Officer) | Sale | 10,000 | 19.88 | 198,750 |
| 2021-11-01 | Kao John E (Chief Executive Officer) | Sale | 70,698 | 19.91 | 1,407,667 |
| 2021-11-01 | Margolis Jeffrey H (Director) | Sale | 1,200 | 19.82 | 23,784 |
| 2021-10-20 | Freeman Robert Thomas (Chief Financial Officer) | Sale | 23,000 | 19.38 | 445,763 |
| 2021-10-14 | Kao John E (Chief Executive Officer) | Sale | 43,097 | 18.83 | 811,430 |
| 2021-10-13 | Kumar Dinesh M. (Chief Medical Officer) | Sale | 10,000 | 18.08 | 180,780 |
| 2021-10-13 | Kao John E (Chief Executive Officer) | Sale | 156,903 | 18.72 | 2,937,694 |
| 2021-10-13 | Margolis Jeffrey H | Sale | 1,200 | 18.00 | 21,600 |
| 2021-04-06 | General Atlantic (aln Hlth), L.p. (Director) | Sale | 2,182,796 | 16.83 | 36,736,456 |
| 2021-04-06 | Maroney Dawn Christine (President, Markets) | Sale | 75,222 | 16.83 | 1,265,986 |
| 2021-04-06 | Warburg Pincus Partners Ii, L.p. (Director) | Sale | 716,624 | 16.83 | 12,060,781 |
| 2021-04-06 | Mcclellan Mark B. (Director) | Sale | 12,103 | 16.83 | 203,693 |
| 2021-04-06 | Margolis Jeffrey H (Director) | Sale | 10,121 | 16.83 | 170,336 |
| 2021-04-06 | Warburg Pincus & Co. (Director) | Sale | 716,624 | 16.83 | 12,060,781 |
| 2021-03-30 | General Atlantic (aln Hlth), L.p. (Director) | Sale | 3,850,819 | 16.83 | 64,809,283 |
| 2021-03-30 | General Atlantic (spv) Gp, Llc (Director) | Sale | 3,850,819 | 16.83 | 64,809,283 |
| 2021-03-30 | Warburg Pincus Partners Ii, L.p. (Director) | Sale | 1,251,670 | 16.83 | 21,065,606 |
| 2021-03-30 | Warburg Pincus & Co. (Director) | Sale | 1,251,670 | 16.83 | 21,065,606 |
Insider trading activities including stock purchases, stock sales, and option exercises
of ALHC listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Alignment Healthcare, Inc. (symbol ALHC,
CIK number 1832466) see
the Securities and Exchange Commission (SEC) website.